Expression of Bone Morphogenetic Proteins in Multiple Sclerosis Lesions

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Bone morphogenetic proteins (BMPs), part of the transforming growth factor-β superfamily, regulate neurogenesis and glial cell differentiation in the adult brain.
• Dysregulation of BMP signaling may contribute to failed remyelination in multiple sclerosis (MS).

Purpose of the Study:

• To investigate the expression of specific BMPs (BMP-2, BMP-4, BMP-5, BMP-7), their receptor (BMPRII), and downstream signaling molecules (pSMAD1/5/8) in lesions from MS and other demyelinating diseases.
• To correlate BMP expression with inflammatory activity and disease type.

Main Methods:

• Immunohistochemical analysis of BMPs, BMPRII, and pSMAD1/5/8 in 42 MS lesions, 12 acute ischemic lesions, 8 PML lesions, and 10 control CNS tissues.
• Histological classification of lesions based on inflammatory activity.
• Quantification of protein expression and colocalization studies.

Main Results:

• BMP-2, BMP-4, BMP-5, BMP-7, BMPRII, and pSMAD1/5/8 were expressed by various cells, including astrocytes, microglia/macrophages, neurons, and oligodendrocytes within MS lesions.
• Oligodendrocytes expressed BMP-2, BMP-7, and pSMAD1/5/8.
• The expression levels of BMPs, BMPRII, and pSMAD1/5/8 significantly correlated with the inflammatory activity of MS lesions, with more pronounced changes observed in MS compared to other white matter diseases.

Conclusions:

• Bone morphogenetic proteins are upregulated in active MS lesions.
• Increased BMP signaling in MS lesions suggests a potential role in the pathogenesis of multiple sclerosis.